Abstract
Helicobacter pylori (H. pylori) infection has been shown to affect the severity and course of gastroesophageal reflux disease (GERD). In this chapter, we have updated these complex relationships based on recent developments in children’s studies, taking into account findings from studies in adults.
The effect of H. pylori on GERD differs according to the anatomical location of H. pylori infection (antrum, corpus, or pangastritis). The type of gastritis is also very important in the course of reflux esophagitis (acute, chronic, atrophic). H. pylori-associated gastritis in the corpus causes hypoacidity while antral gastritis causes hyperacidity. During childhood, H. pylori is associated with antral predominant gastritis and duodenal ulcers.
Gastrin is affected by the gastric localization of H. pylori infection, atrophic changes, and acute/chronic nature. In antral gastritis, hypergastrinemia occurs during the destruction of somatostatin-secreting cells during infection and it triggers acid production, and hyperacidity leads to the development or progression of GER and erosive esophagitis. In cases of antral gastritis that causes hyperacidity, reflux esophagitis may improve after H. pylori is eradicated. Chronic gastritis can lead to atrophic gastritis. Atrophic gastritis causes hypoacidity due to cell damage. In this case, GERD manifestations are provoked by the eradication of H. pylori. Histological studies have shown that atrophic gastritis is rare in children.
The determining factors that trigger H. pylori-related GERD are the location of gastritis in both children and adults, CagA/VacA positivity, and substances released from the stomach which lead to transient lower esophageal sphincter relaxations. Pangastritis causing gastric atrophy is associated with CagA strains and its protective effect against GERD has been demonstrated in corpus gastritis. H. pylori infection with CagA strains is associated with less severe reflux esophagitis in children. But, antral nodularity was found more frequently in CagA-positive patients. VacA, s1b positivity was associated with a lower frequency of esophagitis rate in children. Further studies are required to explain this complex relationship in childhood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BapA:
-
Blood group antigen-binding adhesin A
- BE:
-
Barrett’s esophagus
- BMI:
-
Body mass index
- CagA:
-
Cytotoxin-associated gene A
- DupA:
-
Duodenal ulcer promoting gene A protein
- EAC:
-
Esophageal adenocarcinoma
- GERD:
-
Gastroesophageal Reflux Disease
- H. pylori :
-
Helicobacter pylori
- HpSA:
-
H. pylori stool antigen
- IL:
-
Interleukin
- NO:
-
Nitric oxide
- OipA:
-
Outer inflammatory protein
- OMPs:
-
Outer membrane proteins
- PGs:
-
Pepsinogens
- PPIs:
-
Proton pump inhibitors
- RE:
-
Reflux Esophagitis
- SabA:
-
Sialic acid-binding adhesin
- TLESR:
-
Transient lower esophageal sphincter relaxations
- VacA:
-
Vacuolating cytotoxin A
References
Liu L, Gao H, Wang H, et al. Comparison of esophageal function tests to investigate the effect of helicobacter pylori infection on Gastroesophageal Reflux Disease (GERD). Med Sci Monit. 2018;24:4791–7.
Jones NL, Koletzko S, Goodman K, et al. ESPGHAN, NASPGHAN. Joint ESPGHAN/NASPGHAN guidelines for the management of helicobacter pylori in children and adolescents (update 2016). J Pediatr Gastroenterol Nutr. 2017;64(6):991–1003.
Aguilera Matos I, Diaz Oliva SE, Escobedo AA, Villa Jiménez OM, Velazco Villaurrutia YDC. Helicobacter pylori infection in children. BMJ Paediatr Open. 2020;4(1):e000679.
Yucel O. Interactions between Helicobacter pylori and gastroesophageal reflux disease. Esophagus. 2019;16(1):52–62.
Okuda M, Mabe K, Lin Y, et al. Rapid urine antibody test for Helicobacter pylori infection in adolescents. Pediatr Int. 2017;59:798–802.
Scida S, Russo M, Miraglia C, et al. Relationship between Helicobacter pylori infection and GERD. Acta Biomed. 2018;89(8-S):40–3.
Savarino E, de Bortoli N, De Cassan C, et al. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esop. 2017;30:1–9.
Doulberis M, Papaefthymiou A, Polyzos SA, et al. Helicobacter pylori, sleeve Gastrectomy, and gastroesophageal reflux disease: is there a relation? Obes Surg. 2021;31(4):1839–40.
Kountouras J, Doulberis M, Papaefthymiou A, et al. A perspective on risk factors for esophageal adenocarcinoma: emphasis on helicobacter pylori infection. Ann N Y Acad Sci. 2019;1452:12–7.
El Serag HB, Sonnenberg A, Jamal MM, et al. Corpus gastritis is protective against reflux esophagitis. Gut. 1999;45:181–5.
Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol. 1999;94:3268–72.
Lupu VV, Ignat A, Ciubotariu G, Ciubară A, Moscalu M, Burlea M. Helicobacter pylori infection and gastroesophageal reflux in children. Dis Esophagus. 2016;29:1007–12.
Ristic N, Milovanovic I, Radusinovic M, et al. The comparative analyses of different diagnostic approaches in detection of gastroesophageal reflux disease in children. PLoS One. 2017;12(11):e0187081.
Liu Y-W, Wu J-F, Chen H-L, et al. The correlation between endoscopic reflux esophagitis and combined multichannel intraluminal impedance-pH monitoring in children. Pediatr Neonatol. 2016;57:385–9.
Schwizer W, Fox M. Helicobacter pylori and gastroesophageal reflux disease: a complex organism in a complex host. J Pediatr Gastroenterol Nutr. 2004;38:12–5.
Kalach N, Bontems P, Raymond J. Helicobacter pylori infection in children. Helicobacter. 2017;22(Suppl. 1):e12414.
Yang HR. Updates on the diagnosis of Helicobacter pylori infection in children: what are the differences between adults and children? Pediatr Gastroenterol Hepatol Nutr. 2016;19:96–103.
George S, Mamani N, Lucero Y, et al. Detection of Helicobacter pylori by real-time PCR for 16s rRNA in stools of noninfected healthy children, using ELISA antigen stool test as the gold standard. Helicobacter. 2016;21:606–12.
Cam S. Risk of gastric cancer in children with Helicobacter pylori infection. Asian Pac J Cancer Prev. 2014;15(22):9905–8.
Yu Y, Su L, Wang X, et al. Association between Helicobacter pylori infection and pathological changes in the gastric mucosa in Chinese children. Intern Med. 2014;53:83–8.
Koca T, Serdaroglu F, Dereci S, Akcam M. Peptic ulcers and erosions in children at a pediatric unit in Turkey. Indian Pediatr. 2016;53:692–4.
Eren M, Colak Ö, Işıksoy S, Yavuz A. Effect of H. pylori infection on gastrin, ghrelin, motilin, and gastroesophageal reflux. Turk J Gastroenterol. 2015;26:367–72.
Thor PJ, Blaut U. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease. J Physiol Pharmacol. 2006;57:81–90.
Zullo A, Hassan C, Repici A, Bruzzese V. Helicobacter pylori eradication and reflux disease onset: did gastric acid get “crazy”? World J Gastroenterol. 2013;19:786–9.
Hoepler W, Hammer K, Hammer J. Gastric phenotype in children with Helicobacter pylori infection undergoing upper endoscopy. Scand J Gastroenterol. 2011;46:293–8.
Langner C, Schneider NI, Plieschnegger W, et al. Cardiac mucosa at the gastro-oesophageal junction: indicator of gastrooesophageal reflux disease? Data from a prospective central European multicentre study on histological and endoscopic diagnosis of oesophagitis (histoGERD trial). Histopathology. 2014;65:81–9.
Carvalho MA, Machado NC, Ortolan EV, Rodrigues MA. Upper gastrointestinal histopathological findings in children and adolescents with nonulcer dyspepsia with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2012;55:523–9.
Bedoya A, Garay J, Sanzón F, et al. Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk. Hum Pathol. 2003;34:206–13.
Guiraldes E, Peña A, Duarte I, et al. Nature and extent of gastric lesions in symptomatic Chilean children with Helicobacter pylori associated gastritis. Acta Paediatr. 2002;91:39–44.
Kato S, Nishino Y, Ozawa K, et al. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol. 2004;39:734–8.
Macarthur C, Saunders N, Feldman W. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA. 1995;273:729–34.
Gold BD. Helicobacter pylori infection in children. Curr Probl Pediatr Adolesc Health Care. 2001;31:247–66.
Sherman P, Czinn S, Drumm B, et al. Helicobacter pylori infection in children and adolescents: working group report of the first world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2002;35(Suppl 2):S128–33.
Blecker U. Helicobacter pylori-associated gastroduodenal disease in childhood. South Med J. 1997;90:570–6.15.
Hackelsberger A, Gunther T, Schultze V, et al. Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia. Scand J Gastroenterol. 1999;34:138–43.
Xinias I, Maris T, Mavroudi A, Panteliadis C, Vandenplas Y. Helicobacter pylori infection has no impact on manometric and pH-metric findings in adolescents and young adults with gastroesophageal reflux and antral gastritis: eradication results to no significant clinical improvement. Pediatr Rep. 2013;5:e3.
Daugule I, Rowland M. Helicobacter pylori infection in children. Helicobacter. 2008;13(Suppl 1):41–6.
Hojsak I, Ivković L, Trbojević T, et al. The role of combined 24-h multichannel intraluminal impedance-pH monitoring in the evaluation of children with gastrointestinal symptoms suggesting gastro-esophageal reflux disease. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc. 2016;28:1488–93.
Dent J, Brun J, Fendrick A, et al. An evidence-based appraisal of reflux disease management--the Genval workshop report. Gut. 1999;44(Suppl 2):S1–16.
Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49:498–547.
Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–31.
Moon A, Solomon A, Beneck D, Cunningham-Rundles S. Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2009;49:283–8.
Pilic D, Hankel S, Koerner-Rettberg C, Hamelmann E, Schmidt-Choudhury A. The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease. Scand J Gastroenterol. 2013;48:785–93.
Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr. 2005;40:210–5.
Salvatore S, Hauser B, Devreker T, et al. Esophageal impedance and esophagitis in children: any correlation? J Pediatr Gastroenterol Nutr. 2009;49:566–70.
Dimitrov G, Gottrand F. Does gastric atrophy exist in children? World J Gastroenterol. 2006;12:6274–9.
Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010;16:5181–94.
Kalach N, Bontems P, Koletzko S, et al. Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter study. Eur J Gastroenterol Hepatol. 2010;22:1174–81.
Riddell RH. Pathobiology of Helicobacter pylori infection in children. Can J Gastroenterol. 1999;13:599–603.
Graham DY, Yamaoka YH. H. Pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998;3:145–51.
Levine A, Milo T, Broide E, et al. Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics. 2004;113:54–8.
Iijima K, Koike T, Shimosegawa T. Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol. 2015;6:566.
Pollet S, Gottrand F, Vincent P, et al. Gastroesophageal reflux disease and Helicobacter pylori infection in neurologically impaired children: inter-relations and therapeutic implications. J Pediatr Gastroenterol Nutr. 2004;38:70–4.
Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16:243–50.
Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 2001;49:330–4.
Grande M, Cadeddu F, Villa M, et al. Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol. 2008;6:74.
Ishiki K, Mizuno M, Take S, et al. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol. 2004;2:474–9.
Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729–35.
Souza RF. From reflux esophagitis to esophageal adenocarcinoma. Dig Dis. 2016;34:483–90.
Asaka M, Kato M, Takahashi S, et al. Japanese Society for Helicobacter Research. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1–20.
Fischbach LA, Graham DY, Kramer JR, et al. Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol. 2014;109:357–68.
Kandulski A, Malfertheiner P. Helicobacter pylori and gastroesophageal reflux disease. Curr Opin Gastroenterol. 2014;30(4):402–7.
Rubenstein JH, Inadomi JM, Scheiman J, et al. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol. 2014;12(2):239–45.
Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM. Atrophic gastritis in young children and adolescents. J Clin Pathol. 2005;58:1189–93.
Di Mario F, Goni E. Gastric acid secretion: changes during a century. Best Pract Res Clin Gastroenterol. 2014;28:953–65.
George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric damage and cancer-associated biomarkers in helicobacter pylori-infected children. Front Microbiol. 2020;11:90.
Lopes AI, Palha A, Lopes T, Monteiro L, Oleastro M, Fernandes A. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population. Scand J Gastroenterol. 2006;41:524–31.
Plonka M, Bielanski W, Konturek SJ, et al. Helicobacter pylori infection and serum gastrin, ghrelin and leptin in children of polish shepherds. Dig Liver Dis. 2006;38:91–7.
Monkemuller K, Neumann H, Nocon M, et al. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther. 2008;15:491–6.
Peitz U, Wex T, Vieth M, et al. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. J Gastroenterol Hepatol. 2011;26:82–9.
Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307–19.
Kassem E, Naamna M, Mawassy K, Beer-Davidson G, Muhsen K. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study. Eur J Pediatr. 2017;176:1099–105.
Nakayama Y, Lin Y, Hongo M, Hidaka H, Kikuchi S. Helicobacter pylori infection and its related factors in junior high school students in Nagano prefecture. Japan Helicobacter. 2017;22:e12363.
De Angelis GL, Cavallaro LG, Maffini V, et al. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Dig Dis. 2007;25:206–13.
Nwokolo CU, Freshwater DA, O’Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut. 2003;52:637–40.
Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab. 2003;88:701–4.
Akamizu T, Kangawa K. Translational research on the clinical applications of ghrelin. Endocr J. 2006;53:585–91.
Williams DL, Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr. 2005;135:1320–5.
Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev. 2009;61:430–81.
Takeshita E, Matsuura B, Dong M, Miller LJ, Matsui H, Onji M. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol. 2006;41:223–30.
Deng ZH, Chu B, Xu YZ, Zhang B, Jiang LR. Influence of Helicobacter pylori infection on ghrelin levels in children. World J Gastroenterol. 2012;18:5096–100.
Cindoruk M, Yetkin I, Deger SM, Karakan T, Kan E, Unal S. Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. World J Gastroenterol. 2007;13:1595–159821.
Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol. 2008;14:6327–33.
Osawa H, Nakazato M, Date Y, et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab. 2005;90:10–6.
Isomoto H, Ueno H, Nishi Y, et al. Circulating ghrelin levels in patients with various upper gastrointestinal diseases. Dig Dis Sci. 2005;50:833–8.
Pacifico L, Anania C, Osborn JF, et al. Long-term effects of Helicobacter pylori eradication on circulating ghrelin and leptin concentrations and body composition in prepubertal children. Eur J Endocrinol. 2008;158:323–32.
Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019;11:677.
Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22:e12405.
Altomare A, Guarino MPL, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: update on inflammation and symptom perception. World J Gastroenterol. 2013;19:6523–8.
Luzza F, Pensabene L, Imeneo M, et al. Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacterpylori infection. Helicobacter. 2002;7(1):46–52.
Shavalipour A, Malekpour H, Dabiri H, Kazemian H, Zojaji H, Bahroudi M. Prevalence of cytotoxin-associated genes of Helicobacter pylori among Iranian GERD patients. Gastroenterol Hepatol Bed Bench. 2017;10:178–83.
Azuma T, Yamazaki S, Yamakawa A, et al. Association between diversity in the Src homology 2 domain—containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis. 2004;189:820–7.
Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.
Chiba H, Gunji T, Sato H, et al. A cross-sectional study on the risk factors for erosive esophagitis in young adults. Intern Med. 2012;51:1293–9.
Nejati S, Karkhah A, Darvish H, Validi M, Ebarhimpour S, Nouri HR. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders. Microb Pathog. 2018;117:43–8.
de Brito BB, da Silva FAF, Soares AS, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019;25(37):5578–89.
Daugule I, Rumba I, Engstrand L, Ejderhamn J. Infection with cagA-positive and cagA-negative types of Helicobacter pylori among children and adolescents with gastrointestinal symptoms in Latvia. Eur J Clin Microbiol Infect Dis. 2003;22:622–4.
Vorobjova T, Grünberg H, Oona M, et al. Seropositivity to Helicobacter pylori and CagA protein in schoolchildren of different ages living in urban and rural areas in southern Estonia. Eur J Gastroenterol Hepatol. 2000;12:97–101.
Mourad-Baars P, Hussey S, Jones NL. Helicobacter pylori infection and childhood. Helicobacter. 2010;15:53–9.
Sharma P, Vakil N. Helicobacter pylori and reflux disease. Aliment Pharmacol Ther. 2003;17:287–305.
Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis. 2019;38:55–66.
Sokucu S, Ozden AT, Suoglu OD, et al. CagA positivity and its association with gastroduodenal disease in Turkish children undergoing endoscopic investigation. J Gastroenterol. 2006;41:533–9.
Selimoglu MA, Karabiber H, Otlu B, Yildirim O, Özer A, Samdanci E. Correlation of clinical, endoscopic, and histological findings with virulence factors in children with Helicobacter pylori gastritis. Eur J Gastroenterol Hepatol. 2014;26(6):602–6.
Alam J, Sarkar A, Karmakar BC, Ganguly M, Paul S, Mukhopadhyay AK. Novel virulence factor dupA of Helicobacter pylori as an important risk determinant for disease manifestation: an overview. World J Gastroenterol. 2020;26:4739–52.
Ansari S, Yamaoka Y. Helicobacter pylori BabA in adaptation for gastric colonization. World J Gastroenterol. 2017;23(23):4158–69.
Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol. 2017;23:1521–40.
Kütükcüler N, Aydogdu S, Göksen D, Caglayan S, Yagcyi RV. Increased mucosal inflammatory cytokines in children with Helicobacter pylori-associated gastritis. Acta Paediatr. 1997;86:928–31.
Llorca L, Pérez-Pérez G, Urruzuno P, et al. Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status. Pediatr Infect Dis J. 2017;36:173–8.
Brawner KM, Kumar R, Serrano CA, et al. Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol. 2017;10:1169–77.
Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol. 2018;24:3071–89.
Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5:574–9.
Thorell K, Yahara K, Berthenet E, et al. Correction: rapid evolution of distinct Helicobacter pylori subpopulations in the Americas. PLoS Genet. 2017;13:e1006730.
Kato S, Fujimura S, Kimura K, et al. Non-Helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci. 2006;51:641–6.
Fang HR, Zhang GQ, Cheng JY, et al. Efficacy of lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. Eur J Pediatr. 2019;178:7–16.
Feng J-R, Wang F, Qiu X, et al. Efficacy and safety of probiotic supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis. Eur J Clin Pharmacol. 2017;73:1199–208.
Financial Support
None.
Conflict-of-Interest
None.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yücel, O. (2022). GER and Helicobacter pylori. In: Vandenplas, Y. (eds) Gastroesophageal Reflux in Children. Springer, Cham. https://doi.org/10.1007/978-3-030-99067-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-99067-1_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-99066-4
Online ISBN: 978-3-030-99067-1
eBook Packages: MedicineMedicine (R0)